MLchartDataset catalogue

oral bowel contrast agent NX9

Term · Oncology and biomedicine · MLC-T-ONC-015690

An orally-administered bowel contrast agent that may be used for the imaging of the bowel upon computed tomography (CT). Upon administration, oral bowel contrast agent NX9 may allow for enhanced contrast and visualization of the bowel at CT.

Table 1. Record
IdentifierMLC-T-ONC-015690
FieldOncology and biomedicine
Synonymscontrast agent NX9
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-015690",
  "term": "oral bowel contrast agent NX9",
  "field": "Oncology and biomedicine",
  "definition": "An orally-administered bowel contrast agent that may be used for the imaging of the bowel upon computed tomography (CT). Upon administration, oral bowel contrast agent NX9 may allow for enhanced contrast and visualization of the bowel at CT.",
  "synonyms": [
    "contrast agent NX9"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/oral-bowel-contrast-agent-nx9/"
}

Record 12,308 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.